Abstract

858O Minimal residual disease (MRD) diagnosed by a plasma tumor-agnostic circulating tumor DNA (ctDNA) assay after curative therapy in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) predicts disease relapse and survival

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Phase II trial of valproic acid combined with cisplatin-based chemoradiation in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) patients (pts).
Milena Perez Mak ... Gilberto Castro
Journal of Clinical Oncology | VOL. 35
Milena Perez Mak, et. al.Milena Perez Mak ... Gilberto Castro
20 May 2017
EGFRv3 and PTEN as prognostic markers in head and neck squamous cell carcinoma patients treated with cetuximab.
Alexandre Andre Balieiro Anastacio Da Costa ... Vladmir C Lima
Journal of Clinical Oncology | VOL. 31
Alexandre Andre Balieiro Anastacio Da Costa, et. al.Alexandre Andre Balieiro Anastacio Da Costa ... Vladmir C Lima
20 May 2013
PCN340 TREATMENT OUTCOMES IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK PATIENTS WHO SUBSEQUENTLY PROGRESSED: REAL-WORLD EVIDENCE FROM EUROPE AND THE US
M Tarallo ... H Bailey
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 23
M Tarallo, et. al.M Tarallo ... H Bailey
01 May 2020
The role of PET for predicting nodal response in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) treated with chemoradiotherapy (CRT): Results of a prospective multicenter trial.
Sandra Schmitz ... Aline Van Maanen
Journal of Clinical Oncology | VOL. 35
Sandra Schmitz, et. al.Sandra Schmitz ... Aline Van Maanen
20 May 2017
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Efficacy of TIL Therapy in Advanced Cutaneous Melanoma in the Current Immuno-oncology Era: Updated Systematic Review and Meta-analysis
S Martín-Lluesma ... G Coukos
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
S Martín-Lluesma, et. al.S Martín-Lluesma ... G Coukos
23 Jul 2024
Exploiting the tumor microenvironment and tumor mechanobiology for the treatment of cancer cachexia
Kostas A Papavassiliou ... Athanasios G Papavassiliou
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Kostas A Papavassiliou, et. al.Kostas A Papavassiliou ... Athanasios G Papavassiliou
23 Jul 2024
Immune Checkpoint Inhibitors in Endometrial Cancer: A Cinderella Story
N Colombo ... M Jalving
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
N Colombo, et. al.N Colombo ... M Jalving
22 Jul 2024
Overall survival in first-line HR+/HER2- advanced breast cancer in the era of CDK4/6 inhibitors
Rodrigo Sánchez-Bayona ... Mafalda Oliveira
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
Rodrigo Sánchez-Bayona, et. al.Rodrigo Sánchez-Bayona ... Mafalda Oliveira
22 Jul 2024
View more papers